Copyright Reports & Markets. All rights reserved.

Global Circulating Tumor Cells Market Size, Status and Forecast 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Circulating Tumor Cells Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 CTC Enrichment
      • 1.4.3 CTC Detection
      • 1.4.4 CTC Analysis
    • 1.5 Market by Application
      • 1.5.1 Global Circulating Tumor Cells Market Share by Application (2014-2025)
      • 1.5.2 Breast Cancer
      • 1.5.3 Prostate Cancer
      • 1.5.4 Colorectal Cancer
      • 1.5.5 Lung Cancer
      • 1.5.6 Other
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 Circulating Tumor Cells Market Size
    • 2.2 Circulating Tumor Cells Growth Trends by Regions
      • 2.2.1 Circulating Tumor Cells Market Size by Regions (2014-2025)
      • 2.2.2 Circulating Tumor Cells Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Opportunities

    3 Market Share by Key Players

    • 3.1 Circulating Tumor Cells Market Size by Manufacturers
      • 3.1.1 Global Circulating Tumor Cells Revenue by Manufacturers (2014-2019)
      • 3.1.2 Global Circulating Tumor Cells Revenue Market Share by Manufacturers (2014-2019)
      • 3.1.3 Global Circulating Tumor Cells Market Concentration Ratio (CR5 and HHI)
    • 3.2 Circulating Tumor Cells Key Players Head office and Area Served
    • 3.3 Key Players Circulating Tumor Cells Product/Solution/Service
    • 3.4 Date of Enter into Circulating Tumor Cells Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global Circulating Tumor Cells Market Size by Type (2014-2019)
    • 4.2 Global Circulating Tumor Cells Market Size by Application (2014-2019)

    5 United States

    • 5.1 United States Circulating Tumor Cells Market Size (2014-2019)
    • 5.2 Circulating Tumor Cells Key Players in United States
    • 5.3 United States Circulating Tumor Cells Market Size by Type
    • 5.4 United States Circulating Tumor Cells Market Size by Application

    6 Europe

    • 6.1 Europe Circulating Tumor Cells Market Size (2014-2019)
    • 6.2 Circulating Tumor Cells Key Players in Europe
    • 6.3 Europe Circulating Tumor Cells Market Size by Type
    • 6.4 Europe Circulating Tumor Cells Market Size by Application

    7 China

    • 7.1 China Circulating Tumor Cells Market Size (2014-2019)
    • 7.2 Circulating Tumor Cells Key Players in China
    • 7.3 China Circulating Tumor Cells Market Size by Type
    • 7.4 China Circulating Tumor Cells Market Size by Application

    8 Japan

    • 8.1 Japan Circulating Tumor Cells Market Size (2014-2019)
    • 8.2 Circulating Tumor Cells Key Players in Japan
    • 8.3 Japan Circulating Tumor Cells Market Size by Type
    • 8.4 Japan Circulating Tumor Cells Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia Circulating Tumor Cells Market Size (2014-2019)
    • 9.2 Circulating Tumor Cells Key Players in Southeast Asia
    • 9.3 Southeast Asia Circulating Tumor Cells Market Size by Type
    • 9.4 Southeast Asia Circulating Tumor Cells Market Size by Application

    10 India

    • 10.1 India Circulating Tumor Cells Market Size (2014-2019)
    • 10.2 Circulating Tumor Cells Key Players in India
    • 10.3 India Circulating Tumor Cells Market Size by Type
    • 10.4 India Circulating Tumor Cells Market Size by Application

    11 Central & South America

    • 11.1 Central & South America Circulating Tumor Cells Market Size (2014-2019)
    • 11.2 Circulating Tumor Cells Key Players in Central & South America
    • 11.3 Central & South America Circulating Tumor Cells Market Size by Type
    • 11.4 Central & South America Circulating Tumor Cells Market Size by Application

    12 International Players Profiles

    • 12.1 Menarini-Silicon Biosystems
      • 12.1.1 Menarini-Silicon Biosystems Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 Circulating Tumor Cells Introduction
      • 12.1.4 Menarini-Silicon Biosystems Revenue in Circulating Tumor Cells Business (2014-2019)
      • 12.1.5 Menarini-Silicon Biosystems Recent Development
    • 12.2 Qiagen (Adnagen)
      • 12.2.1 Qiagen (Adnagen) Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 Circulating Tumor Cells Introduction
      • 12.2.4 Qiagen (Adnagen) Revenue in Circulating Tumor Cells Business (2014-2019)
      • 12.2.5 Qiagen (Adnagen) Recent Development
    • 12.3 Advanced Cell Diagnostics
      • 12.3.1 Advanced Cell Diagnostics Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 Circulating Tumor Cells Introduction
      • 12.3.4 Advanced Cell Diagnostics Revenue in Circulating Tumor Cells Business (2014-2019)
      • 12.3.5 Advanced Cell Diagnostics Recent Development
    • 12.4 ApoCell
      • 12.4.1 ApoCell Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 Circulating Tumor Cells Introduction
      • 12.4.4 ApoCell Revenue in Circulating Tumor Cells Business (2014-2019)
      • 12.4.5 ApoCell Recent Development
    • 12.5 Epic Sciences
      • 12.5.1 Epic Sciences Company Details
      • 12.5.2 Company Description and Business Overview
      • 12.5.3 Circulating Tumor Cells Introduction
      • 12.5.4 Epic Sciences Revenue in Circulating Tumor Cells Business (2014-2019)
      • 12.5.5 Epic Sciences Recent Development
    • 12.6 Greiner Bio-one GmbH
      • 12.6.1 Greiner Bio-one GmbH Company Details
      • 12.6.2 Company Description and Business Overview
      • 12.6.3 Circulating Tumor Cells Introduction
      • 12.6.4 Greiner Bio-one GmbH Revenue in Circulating Tumor Cells Business (2014-2019)
      • 12.6.5 Greiner Bio-one GmbH Recent Development
    • 12.7 Cynvenio
      • 12.7.1 Cynvenio Company Details
      • 12.7.2 Company Description and Business Overview
      • 12.7.3 Circulating Tumor Cells Introduction
      • 12.7.4 Cynvenio Revenue in Circulating Tumor Cells Business (2014-2019)
      • 12.7.5 Cynvenio Recent Development
    • 12.8 SurExamBio-Tech
      • 12.8.1 SurExamBio-Tech Company Details
      • 12.8.2 Company Description and Business Overview
      • 12.8.3 Circulating Tumor Cells Introduction
      • 12.8.4 SurExamBio-Tech Revenue in Circulating Tumor Cells Business (2014-2019)
      • 12.8.5 SurExamBio-Tech Recent Development
    • 12.9 Fluxion Biosciences
      • 12.9.1 Fluxion Biosciences Company Details
      • 12.9.2 Company Description and Business Overview
      • 12.9.3 Circulating Tumor Cells Introduction
      • 12.9.4 Fluxion Biosciences Revenue in Circulating Tumor Cells Business (2014-2019)
      • 12.9.5 Fluxion Biosciences Recent Development
    • 12.10 Ikonisys
      • 12.10.1 Ikonisys Company Details
      • 12.10.2 Company Description and Business Overview
      • 12.10.3 Circulating Tumor Cells Introduction
      • 12.10.4 Ikonisys Revenue in Circulating Tumor Cells Business (2014-2019)
      • 12.10.5 Ikonisys Recent Development
    • 12.11 Hangzhou Watson Biotech
    • 12.12 Biocept
    • 12.13 CytoTrack
    • 12.14 Guangzhou Wondfo Biotech
    • 12.15 Celsee
    • 12.16 Clearbridge Biomedics
    • 12.17 ANGLE plc

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Regions
    • 13.2 United States
    • 13.3 Europe
    • 13.4 China
    • 13.5 Japan
    • 13.6 Southeast Asia
    • 13.7 India
    • 13.8 Central & South America
    • 13.9 Market Size Forecast by Product (2019-2025)
    • 13.10 Market Size Forecast by Application (2019-2025)

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 12.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      Circulating tumor cells are cancer cells that have detached from the tumor and are found at extremely low levels in the bloodstream. The value of capturing and counting CTCs is evolving as more research data is gathered about the utility of these markers in monitoring disease progression and potentially guiding personalized cancer therapy.
      USA is the largest supplier of CTCs Products, with a revenue market share nearly 47.41% in 2017. Europe is the second largest supplier of CTCs products, enjoying revenue market share nearly 26.24% in 2017. Asia has the highest growth rate. Vendors recognize the importance of this region, particularly in China, India and are working towards penetrating this market by strengthening their sales and distribution networks.
      In 2018, the global Circulating Tumor Cells market size was 730 million US$ and it is expected to reach 3230 million US$ by the end of 2025, with a CAGR of 20.4% during 2019-2025.

      This report focuses on the global Circulating Tumor Cells status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Circulating Tumor Cells development in United States, Europe and China.

      The key players covered in this study
      Menarini-Silicon Biosystems
      Qiagen (Adnagen)
      Advanced Cell Diagnostics
      ApoCell
      Epic Sciences
      Greiner Bio-one GmbH
      Cynvenio
      SurExamBio-Tech
      Fluxion Biosciences
      Ikonisys
      Hangzhou Watson Biotech
      Biocept
      CytoTrack
      Guangzhou Wondfo Biotech
      Celsee
      Clearbridge Biomedics
      ANGLE plc

      Market segment by Type, the product can be split into
      CTC Enrichment
      CTC Detection
      CTC Analysis

      Market segment by Application, split into
      Breast Cancer
      Prostate Cancer
      Colorectal Cancer
      Lung Cancer
      Other

      Market segment by Regions/Countries, this report covers
      United States
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global Circulating Tumor Cells status, future forecast, growth opportunity, key market and key players.
      To present the Circulating Tumor Cells development in United States, Europe and China.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by product type, market and key regions.

      In this study, the years considered to estimate the market size of Circulating Tumor Cells are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025
      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now